Page 1 of Clinical Trials for Drug dabigatran etexilate 150 mg, 24 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Bioequivalence of Two Different Capsule Types of Dabigatran
Last Updated: October 19, 2011
Condition(s): Healthy
2
Completed
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
Last Updated: February 10, 2011
Condition(s): Thromboembolism
3
Completed
RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery
Last Updated: May 18, 2012
Condition(s): Arthroplasty, Replacement, Knee; Thromboembolism
4
Completed
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
Last Updated: May 18, 2012
Condition(s): Venous Thromboembolism
5
Completed
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
Last Updated: May 18, 2012
Condition(s): Arthroplasty, Replacement, Knee; Venous Thrombosis
6
Completed
Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects
Last Updated: October 19, 2011
Condition(s): Healthy
7
Completed
A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin
Last Updated: January 7, 2011
Condition(s): Atrial Fibrillation
8
Completed
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp VTE
Last Updated: June 28, 2011
Condition(s): Thromboembolism
9
Completed
Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis
Last Updated: August 23, 2011
Condition(s): Cardiovascular Diseases; Kidney Failure, Chronic
10
Completed
RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome
Last Updated: May 18, 2012
Condition(s): Coronary Disease
11
Completed
Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention
Last Updated: May 18, 2012
Condition(s): Heart Catheterization
12
Completed
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
Last Updated: February 17, 2011
Condition(s): Arthroplasty, Replacement, Knee; Thromboembolism
13
Recruiting
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
Last Updated: May 2, 2012
Condition(s): Atrial Fibrillation
14
Completed
Secondary Prevention of Venous Thrombo Embolism (VTE).
Last Updated: May 18, 2012
Condition(s): Thromboembolism
15
Completed
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
Last Updated: January 20, 2011
Condition(s): Venous Thromboembolism
16
Completed
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
Last Updated: May 18, 2012
Condition(s): Thromboembolism; Arthroplasty, Replacement, Hip
17
Completed
A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)
Last Updated: February 20, 2012
Condition(s): Thrombosis
18
Recruiting
Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery
Last Updated: May 2, 2012
Condition(s): Arthroplasty, Replacement; Thromboembolism
19
Completed
Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics
Last Updated: June 30, 2011
Condition(s): Venous Thromboembolism
20
Terminated
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
Last Updated: March 3, 2011
Condition(s): Atrial Fibrillation; Stroke

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+dabigatran+etexilate+150+mg

Page 1 of Clinical Trials for Drug dabigatran etexilate 150 mg, 24 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About